Versatility of Caenorhabditis elegans as a Model Organism for Evaluating Foodborne Neurotoxins and Food Bioactive Compounds in Nutritional Neuroscience
- PMID: 39863742
- DOI: 10.1007/s12035-025-04705-y
Versatility of Caenorhabditis elegans as a Model Organism for Evaluating Foodborne Neurotoxins and Food Bioactive Compounds in Nutritional Neuroscience
Abstract
Epidemiological evidence has shown that the regular ingestion of vegetables and fruits is associated with reduced risk of developing chronic diseases. The introduction of the 3Rs (replacement, reduction, and refinement) principle into animal experiments has led to the use of valid, cost-effective, and efficient alternative and complementary invertebrate animal models which are simpler and lower in the phylogenetic hierarchy. Caenorhabditis elegans (C. elegans), a nematode with a much simpler anatomy and physiology compared to mammals, share similarities with humans at the cellular and molecular levels, thus making it a valid model organism in neurotoxicology. This review explores the versatility of C. elegans in elucidating the neuroprotective mechanisms elicited by food bioactive compounds against neurotoxic effects of food- and environmental-related contaminants. Several signaling pathways linked to the molecular basis of neuroprotection exerted by bioactive compounds in chemically induced or transgenic C. elegans models of neurodegenerative diseases are also discussed. Specifically, the modulatory effects of bioactive compounds on the DAF-16/FoxO and SKN-1/Nrf2 signaling pathways, stress resistance- and autophagy-related genes, and antioxidant defense enzyme activities were highlighted. Altogether, C. elegans represent a valuable model in nutritional neuroscience for the identification of promising neuroprotective agents and neurotherapeutic targets which could help in overcoming the limitations of current therapeutic agents for neurotoxicity and neurodegenerative diseases.
Keywords: C. elegans; Bioactive compounds; Food safety; Neuronutrition; Neurotoxicology.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical Approval: This is a review manuscript which requires no ethical approval. Consent to Publication: The content of this manuscript is original. It does not contain data and pictures of any person. Hence, no consent from any person or organization is required to publish it. Conflict of Interest: The authors declare no competing interests.
Similar articles
-
Hibiscus sabdariffa L. extract prolongs lifespan and protects against amyloid-β toxicity in Caenorhabditis elegans: involvement of the FoxO and Nrf2 orthologues DAF-16 and SKN-1.Eur J Nutr. 2020 Feb;59(1):137-150. doi: 10.1007/s00394-019-01894-w. Epub 2019 Feb 1. Eur J Nutr. 2020. PMID: 30710163
-
Comparing the Neuroprotective Effects of Caffeic Acid in Rat Cortical Slices and Caenorhabditis elegans: Involvement of Nrf2 and SKN-1 Signaling Pathways.Neurotox Res. 2020 Feb;37(2):326-337. doi: 10.1007/s12640-019-00133-8. Epub 2019 Nov 26. Neurotox Res. 2020. PMID: 31773641 Free PMC article.
-
Isoliquiritigenin exerts antioxidant activity in Caenorhabditis elegans via insulin-like signaling pathway and SKN-1.Phytomedicine. 2019 Mar 1;55:119-124. doi: 10.1016/j.phymed.2018.07.004. Epub 2018 Jul 20. Phytomedicine. 2019. PMID: 30668421
-
Effects of NAD+ in Caenorhabditis elegans Models of Neuronal Damage.Biomolecules. 2020 Jul 2;10(7):993. doi: 10.3390/biom10070993. Biomolecules. 2020. PMID: 32630651 Free PMC article. Review.
-
Caenorhabditis elegans: A Convenient In Vivo Model for Assessing the Impact of Food Bioactive Compounds on Obesity, Aging, and Alzheimer's Disease.Annu Rev Food Sci Technol. 2018 Mar 25;9:1-22. doi: 10.1146/annurev-food-030117-012709. Epub 2017 Dec 20. Annu Rev Food Sci Technol. 2018. PMID: 29261338 Review.
Cited by
-
Neuroprotective propensity of N-(5-chloro-2-hydroxyphenyl)-2-(morpholin-4-yl-methyl) benzamide, an inventive calcineurin inhibitor, in biological models of Parkinson's disease.3 Biotech. 2025 Jun;15(6):149. doi: 10.1007/s13205-025-04314-5. Epub 2025 May 2. 3 Biotech. 2025. PMID: 40321716
References
-
- Badaeva AV, Danilov AB, Clayton P, Moskalev AA, Karasev AV, Tarasevich AF, Vorobyeva YD, Novikov VN (2023) Perspectives on neuronutrition in prevention and treatment of neurological disorders. Nutrients 15(11):2505. https://doi.org/10.3390/nu15112505 - DOI - PubMed - PMC
-
- Chongtham N, Bisht MS, Premlata T, Bajwa HK, Sharma V, Santosh O (2022) Quality improvement of bamboo shoots by removal of antinutrients using different processing techniques: a review. J Food Sci Technol 59(1):1–11. https://doi.org/10.1007/s13197-021-04987-9 - DOI - PubMed
-
- Duraiswamy A, Sneha ANM, Jebakani KS, Selvaraj S, Pramitha JL, Selvaraj R, Petchiammal KI, Kather Sheriff S, Thinakaran J, Rathinamoorthy S, Kumar PR (2023) Genetic manipulation of anti-nutritional factors in major crops for a sustainable diet in future. Front Plant Sci 13:1070398. https://doi.org/10.3389/fpls.2022.1070398 - DOI - PubMed - PMC
-
- Mao XY, Yin XX, Guan QW, Xia QX, Yang N, Zhou HH, Liu ZQ, Jin WL (2021) Dietary nutrition for neurological disease therapy: current status and future directions. Pharmacol Ther 226:107861. https://doi.org/10.1016/j.pharmthera.2021.107861 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous